Azenta, Inc.
Every calculator, already run for AZTA
Open the full toolkit →You have the numbers on AZTA. Get the argument.
A written report on which of these readings actually decide the outcome for Azenta, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
6 analysts covering AZTAAnalyst Price Target Disagreement for Azenta, Inc.
Wall Street's bull case implies +6% from the current price; the bear case implies -33%. A 39% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for AZTA
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Azenta, Inc.
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. Th…
AZTA — frequently asked
Is AZTA a buy right now?
Wall Street's consensus rating on Azenta, Inc. is Buy across 6 analysts, with a mean price target of $39.40 (-19% vs. the current $48.90). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is AZTA overvalued?
AZTA trades at — trailing earnings, against a DCF fair value of $35 per share. The current price implies 11% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is AZTA's next earnings date?
Azenta, Inc. is next scheduled to report earnings around Feb 3, 2027. A full AZTA research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Azenta, Inc.?
Analysts covering Azenta, Inc. (AZTA) range from a bear-case target of $33.00 to a bull-case high of $52.00, with a mean consensus target of $39.40 across 5 analysts. The spread of $19.00 (39% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Azenta, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Azenta, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full AZTA research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Azenta, Inc., in minutes. 3 free reports included with every account — no credit card required.